Pharmaceutical compositions comprising erythropoietin for treatment of cancer
US6579525B1 · kind B1 · utility
7Cited by
0References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 5, 2000 |
| Grant date | Jun 17, 2003 |
| Priority date | — |
| Expiry date | Oct 5, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions comprising erythropoietin are provided for treatment of cancer, particularly for treatment of multiple myeloma. Erythropoietin was found to be effective for inhibition of tumor growth, triggering of tumor regression, stimulation of the natural immunological defense against cancer and/or inhibition of cancer cell metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.